• LAST PRICE
    2.1600
  • TODAY'S CHANGE (%)
    Trending Down-0.0500 (-2.2624%)
  • Bid / Lots
    2.1600/ 10
  • Ask / Lots
    2.2600/ 6
  • Open / Previous Close
    2.2200 / 2.2100
  • Day Range
    Low 2.1400
    High 2.2250
  • 52 Week Range
    Low 1.7900
    High 15.8050
  • Volume
    707,449
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 2.21
TimeVolumeVTYX
09:32 ET87492.225
09:34 ET91512.205
09:36 ET122042.21
09:38 ET25002.2
09:39 ET37442.205
09:41 ET67262.21
09:43 ET1002.21
09:48 ET21012.205
09:50 ET39022.195
09:52 ET13002.19
09:54 ET1002.185
09:56 ET62522.1713
09:57 ET17002.1799
09:59 ET2002.175
10:01 ET2362.1708
10:03 ET11502.1799
10:06 ET49312.18
10:08 ET3002.175
10:10 ET1002.175
10:12 ET19342.171
10:14 ET46132.1793
10:15 ET13002.175
10:17 ET60262.195
10:19 ET1002.195
10:21 ET54942.2
10:24 ET20002.205
10:26 ET7542.21
10:28 ET7002.205
10:30 ET3522.2
10:32 ET13502.1952
10:37 ET5002.195
10:39 ET3752.1992
10:42 ET3002.185
10:44 ET5002.19
10:48 ET515002.1885
10:50 ET12952.2
10:51 ET109612.2
10:53 ET3002.2
10:55 ET66622.205
10:57 ET1002.21
11:00 ET13002.1992
11:04 ET16802.1977
11:06 ET16262.195
11:08 ET4002.2
11:09 ET1002.195
11:13 ET28832.195
11:18 ET12002.2
11:22 ET25002.21
11:24 ET4782.21
11:26 ET4402.215
11:27 ET3002.21
11:31 ET11062.21
11:33 ET2402.2052
11:36 ET3002.21
11:38 ET25582.21
11:40 ET8862.215
11:42 ET1002.2192
11:47 ET8002.215
11:49 ET1002.215
11:54 ET86612.2
11:56 ET22522.21
12:02 ET4002.205
12:05 ET21002.2005
12:07 ET16212.195
12:09 ET2002.195
12:14 ET2002.195
12:16 ET13902.2
12:18 ET13002.195
12:20 ET9002.195
12:21 ET10922.1961
12:23 ET28002.2
12:25 ET8002.195
12:27 ET1002.19
12:34 ET3952.195
12:38 ET7642.18
12:39 ET64752.18
12:41 ET2292.19
12:43 ET1002.185
12:48 ET57942.175
12:50 ET24792.175
12:52 ET10802.175
12:54 ET1002.1769
12:56 ET2002.175
12:57 ET122362.165
12:59 ET121992.165
01:01 ET7002.165
01:03 ET588232.16
01:06 ET612442.16
01:08 ET52962.155
01:10 ET46402.145
01:12 ET7022.14
01:14 ET5002.145
01:15 ET109762.155
01:17 ET40142.1578
01:19 ET21732.155
01:21 ET17002.16
01:24 ET19582.165
01:26 ET11002.1693
01:30 ET4702.1624
01:32 ET37312.165
01:33 ET9002.165
01:35 ET19702.175
01:37 ET24932.175
01:39 ET12902.17
01:42 ET38262.17
01:44 ET21392.175
01:46 ET8002.175
01:48 ET9362.17
01:53 ET4632.175
01:57 ET6002.175
02:00 ET395762.175
02:02 ET12002.1754
02:04 ET1132.1713
02:06 ET4612.1791
02:08 ET32992.18
02:09 ET21772.175
02:11 ET1002.175
02:13 ET7212.175
02:15 ET5202.175
02:20 ET10002.1792
02:22 ET22602.1692
02:27 ET37752.16
02:29 ET84432.16
02:31 ET19902.1696
02:33 ET15112.16
02:36 ET15422.165
02:38 ET16122.16
02:40 ET8002.165
02:42 ET1002.165
02:44 ET4002.165
02:45 ET1002.16
02:51 ET24932.16
03:00 ET1052.165
03:02 ET68292.165
03:03 ET18722.16
03:05 ET6822.165
03:07 ET12622.165
03:09 ET9452.17
03:12 ET70792.165
03:14 ET2002.16
03:16 ET6622.16
03:18 ET9562.1692
03:20 ET16312.165
03:23 ET27952.165
03:25 ET36392.16
03:27 ET14802.16
03:34 ET285982.18
03:36 ET48332.175
03:38 ET1002.1745
03:39 ET10292.175
03:41 ET3492.175
03:43 ET6002.175
03:45 ET7002.175
03:48 ET44212.17
03:50 ET10522.175
03:52 ET16362.1713
03:54 ET27492.175
03:56 ET11152.175
03:57 ET77622.175
03:59 ET707522.16
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesVTYX
Ventyx Biosciences Inc
156.2M
-0.8x
---
United StatesGALT
Galectin Therapeutics Inc
156.9M
-3.2x
---
United StatesSKYE
Skye Bioscience Inc
154.4M
-1.3x
---
United StatesLPTX
Leap Therapeutics Inc
159.6M
-1.9x
---
United StatesVIGL
Vigil Neuroscience Inc
152.6M
-1.8x
---
United StatesCYDY
Cytodyn Inc
160.2M
-5.4x
---
As of 2024-10-31

Company Information

Ventyx Biosciences, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing a pipeline of small molecule product candidates to address a range of inflammatory diseases with unmet need. The Company’s pipeline includes VTX002 (S1P1R Modulator), VTX958 (TYK2 Inhibitor), and VTX2735 and VTX3232 (NLRP3 Inhibitor Portfolio). VTX002 is a sphingosine 1 phosphate receptor (S1P1R) modulator in Phase II development for patients with moderately to severely active ulcerative colitis (UC). VTX958 is an oral, selective clinical-stage inhibitor of tyrosine kinase type 2 (TYK2), an intracellular signaling kinase in the Janus kinase (JAK) family that regulates chronic inflammation in immune-mediated diseases. Its third product candidate, VTX2735, is a peripheral-targeted NOD-like receptor protein 3 (NLRP3) inflammasome inhibitor. In addition to VTX2735, it is also developing VTX3232, its lead CNS-penetrant NLRP3 inhibitor in Phase 1 development.

Contact Information

Headquarters
12790 El Camino Real, Suite 200SAN DIEGO, CA, United States 92130
Phone
858-945-2393
Fax
302-655-5049

Executives

Executive Chairperson of the Board
Sheila Gujrathi
President, Chief Executive Officer, Founder, Director
Raju Mohan
Interim Principal Financial Officer, Interim Principal Accounting Officer
Roy Gonzales
Chief Operating Officer
Matthew Moore
Chief Scientific Officer
John Nuss

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$156.2M
Revenue (TTM)
$0.00
Shares Outstanding
70.7M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-2.79
Book Value
$4.12
P/E Ratio
-0.8x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.